- Author: Robert P Hoffman, MD; Chief Editor: Stephen Kemp, MD, PhD more...
These agents are used to treat acute suppurative thyroiditis. First-line antibiotic choices to treat acute thyroiditis include parenteral penicillin or ampicillin. These drugs cover most of the gram-positive cocci and anaerobes that cause the disease.
Antibiotic with activity against gram-positive, some gram-negative, and some anaerobic bacteria. Penicillin binds to PBPs, inhibiting bacterial cell wall growth.
Penicillin antibiotic with activity against gram-positive and some gram-negative bacteria. Binds to PBPs, inhibiting bacterial cell wall growth.
These drugs are used to decrease discomfort in patients with subacute thyroiditis.
Most patients respond well to aspirin as a first-line therapy. Treats mild to moderate pain. Inhibits prostaglandin synthesis, which prevents formation of platelet-aggregating thromboxane A2.
Used when aspirin is ineffective in controlling discomfort in patients with subacute thyroiditis. May decrease inflammation by reversing increased capillary permeability and suppressing PMN activity.
Beta-adrenergic blocking agents
Many signs and symptoms of hyperthyroidism are due to increased beta-adrenergic sensitivity. In particular, these include the hemodynamic abnormalities of tachycardia and hypertension. Beta-adrenergic blockade can reduce many of these symptoms. These agents are the DOC in treating cardiac arrhythmias that result from hyperthyroidism. These agents control cardiac and psychomotor manifestations within minutes.
Can be immediately initiated in patients with hyperthyroidism due to either subacute thyroiditis or autoimmune thyroiditis. Because of the self-limiting nature of these situations, they may be the only drugs needed.
These agents are used to treat hypothyroidism due to autoimmune thyroiditis. Use thyroid-stimulating hormone (TSH) levels to monitor dose and keep them within the reference range.
Levothyroxine is a synthetic form of thyroxine involved in normal growth, metabolism, and development.
Iacovelli P, Sinagra JL, Vidolin AP, et al. Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology. 2005. 210(1):26-30. [Medline].
Fisher DA, Greueters, A. Thyroid disorders in childhood and adolesence. Sperling MA. Pediatric Endocrinology,. 3rd ed. Philadelphia, PA: Sunders Elevier; 2008. 227-53.
Demirbilek H, Kandemir N, Gonc EN, Ozon A, Alikasifoglu A, Yordam N. Hashimoto's thyroiditis in children and adolescents: a retrospective study on clinical, epidemiological and laboratory properties of the disease. J Pediatr Endocrinol Metab. 2007 Nov. 20(11):1199-205. [Medline].
Fava A, Oliverio R, Giuliano S, Parlato G, Michniewicz A, Indrieri A, et al. Clinical Evolution of Autoimmune Thyroiditis in Children and Adolescents. Thyroid. 2009 Feb 18. [Medline].
Sattar N, Lazare F, Kacer M, Aguayo-Figueroa L, Desikan V, Garcia M, et al. Celiac disease in children, adolescents, and young adults with autoimmune thyroid disease. J Pediatr. 2011 Feb. 158(2):272-5.e1. [Medline].
de Vries L, Bulvik S, Phillip M. Chronic autoimmune thyroiditis in children and adolescents: at presentation and during long-term follow-up. Arch Dis Child. 2009 Jan. 94(1):33-7. [Medline].
Dobert N, Balzer K, Diener J, Wegscheider K, Vaupel R, Grunwald F. Thyroid sonomorphology, thyroid peroxidase antibodies and thyroid function: new epidemiological data in unselected German employees. Nuklearmedizin. 2008. 47(5):194-9. [Medline].
Karges B, Muche R, Knerr I, et al. Levothyroxine in euthyroid autoimmune thyroiditis and type 1 diabetes: a randomized, controlled trial. J Clin Endocrinol Metab. 2007 May. 92(5):1647-52. [Medline].
Svensson J, Ericsson UB, Nilsson P, et al. Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditis. J Clin Endocrinol Metab. 2006 May. 91(5):1729-34. [Medline].
Bauer DC, Brown AN. Sensitive thyrotropin and free thyroxine testing in outpatients. Are both necessary?. Arch Intern Med. 1996 Nov 11. 156(20):2333-7. [Medline].
Bogazzi F, Bartalena L, Tomisti L, et al. Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. J Clin Endocrinol Metab. 2007 Feb. 92(2):556-62. [Medline].
Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med. 1996 Jul 11. 335(2):99-107. [Medline].
de Kerdanet M, Lucas J, Lemee F, Lecornu M. Turner's syndrome with X-isochromosome and Hashimoto's thyroiditis. Clin Endocrinol (Oxf). 1994 Nov. 41(5):673-6. [Medline].
Hay ID. Thyroiditis: a clinical update. Mayo Clin Proc. 1985 Dec. 60(12):836-43. [Medline].
Kennedy RL, Jones TH, Cuckle HS. Down's syndrome and the thyroid. Clin Endocrinol (Oxf). 1992 Dec. 37(6):471-6. [Medline].
Mandac JC, Chaudhry S, Sherman KE, Tomer Y. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology. 2006 Apr. 43(4):661-72. [Medline].
McCanlies E, O''Leary LA, Foley TP, et al. Hashimoto''s thyroiditis and insulin-dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function. J Clin Endocrinol Metab. 1998 May. 83(5):1548-51. [Medline]. [Full Text].
Nordyke RA, Gilbert FI Jr, Miyamoto LA, Fleury KA. The superiority of antimicrosomal over antithyroglobulin antibodies for detecting Hashimoto's thyroiditis. Arch Intern Med. 1993 Apr 12. 153(7):862-5. [Medline].
Pearce EN, Bogazzi F, Martino E, et al. The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease. Thyroid. 2003 Jul. 13(7):643-8. [Medline].
Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003 Jun 26. 348(26):2646-55. [Medline].
Rother KI, Zimmerman D, Schwenk WF. Effect of thyroid hormone treatment on thyromegaly in children and adolescents with Hashimoto disease. J Pediatr. 1994 Apr. 124(4):599-601. [Medline].
Mormile R. Celiac disease and Hashimoto's thyroiditis: a shared plot?. Int J Colorectal Dis. 2015 Aug 23. [Medline].
Tomer Y, Dolan LM, Kahaly G, Divers J, D'Agostino RB Jr, et al. Genome wide identification of new genes and pathways in patients with both autoimmune thyroiditis and type 1 diabetes. J Autoimmun. 2015 Jun. 60:32-9. [Medline].